药品
肝损伤
医学
荧光
药物不良反应
重症监护医学
药理学
量子力学
物理
作者
Dong-qin Sun,Zhenzhen Chen,Jiali Hu,Hua‐jin Zeng,Lingbo Qu,Zhaohui Li
标识
DOI:10.1016/j.cclet.2021.12.043
摘要
Drug-induced liver injury (DILI) is a common and serious adverse drug reaction. At present, DILI is perfectly diagnozed in clinical settings using Roussel Uclaf causality assessment method (RUCAM) in its original version published 1993 and its updated version published 2016, well established worldwide as a diagnostic algorithm with a high sensitivity and specificity. Nevertheless, the search for additional detection methods supporting RUCAM continues. In recent years, with the development of optical imaging technology, fluorescent probes have gradually shown great advantages in the detection and diagnosis of DILI markers such as high sensitivity, anti-interference, real-time monitoring and non-invasive measurement. In this review, the recent advances of fluorescent probes for evaluation of DILI in experimental studies were summarized according to various markers of DILI. We believe that learning about the design and practical application of these probes will contribute to the further development of detection sensors for DILI markers.
科研通智能强力驱动
Strongly Powered by AbleSci AI